SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
-9.33%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$363M
AUM Growth
+$363M
(-16%)
Cap. Flow
-$50M
Cap. Flow
% of AUM
-13.78%
Top 10 Holdings %
Top 10 Hldgs %
99.83%
Holding
15
New
1
Increased
1
Reduced
5
Closed
4
Top Buys
| 1 |
Innoviva
INVA
|
$21.1M |
| 2 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$8.63M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$29M |
| 2 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
$16.9M |
| 3 |
Pacira BioSciences
PCRX
|
$14.7M |
| 4 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$7.87M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$4.75M |
Sector Composition
| 1 | Healthcare | 83.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $160M | 44.03% | 12,850,000 | – | – |
|
2
Biogen
BIIB
$19.4B
| $87.9M | 24.21% | 310,000 | – | – |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $59.5M | 16.38% | 1,752,000 | – | – |
|
|
4
Innoviva
INVA
$1.29B
| $31.8M | 8.77% | 2,975,000 +1,975,000 | +198% | +$21.1M |
|
|
NVLN
5
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $8.63M | 2.38% | +1,025,000 | New | +$8.63M |
|
|
ITCI
6
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.43M | 1.5% | 360,000 -315,000 | -47% | -$4.75M |
|
|
ADXS
7
DELISTED
Advaxis, Inc.
ADXS
| $3.58M | 0.99% | 500,000 -100,000 | -17% | -$716K |
|
|
VVUS
8
DELISTED
Vivus Inc
VVUS
| $2.96M | 0.82% | 2,573,943 | – | – |
|
|
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.88M | 0.52% | 1,447,906 -13,031,146 | -90% | -$16.9M |
|
|
AVEO
10
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $917K | 0.25% | 1,700,000 -300,000 | -15% | -$162K |
|
11
AbbVie
ABBV
$372B
| $626K | 0.17% | 10,000 -22,000 | -69% | -$1.38M |
|
12
Quest Diagnostics
DGX
$20.3B
| – | – | -50,000 | Closed | -$4.23M |
|
|
13
Pacira BioSciences
PCRX
$1.2B
| – | – | -430,000 | Closed | -$14.7M |
|
|
ARRY
14
DELISTED
Array Biopharma Inc
ARRY
| – | – | -4,300,000 | Closed | -$29M |
|
|
AEGR
15
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| – | – | -2,649,000 | Closed | -$7.87M |
|